You searched for "infection"
Is dissection of level IV necessary in patients with negative neck oral cancer?
Supraomohyoid neck dissection (SOHND) refers to the removal of lymph nodes contained in levels I-III and is currently referred to as a selective neck dissection levels I-III. This type of neck dissection has been frequently used in the management of...The HEARO Procedure for cochlear implantation
Cochlear implants have become the state-of-the-art treatment for profound to severe sensorineural hearing loss. Since its popularisation, many aspects of this technology have constantly been optimised. Processors have become smaller, are worn behind the ear and are even water resistant....BACO International 2018: Key Speakers
Prof Aldo C Stamm, MD, MSc, PhD Anatomy of the paranasal sinuses and skull base, and breaking the paradigms in severe spontaneous epistaxis It is a true honour to participate as an invited faculty member at the upcoming BACO International...IFOS Dubai 2023
Hussain Abdul Rahman Al Rand, Msc (Cairo), German Board (Facharzt), FRCS (Edin), President, IFOS World Congress Dubai, 2023; Assistant Under Secretary Public Health, Ministry of Health and Prevention, UAE; Vice President, IFOS; President, ARABFOS, GCC ORL Head and Neck Society,...
Facial nerve grafting – what’s the wait?
An uninterrupted facial nerve after resection of cerebellopontine angle (CPA) tumour does not always translate into preserved facial animation. Fortunately there is a high probability spontaneous recovery may occur and hence patients are typically observed for 12 months postoperatively. However,...
Technique for benign tumours in the tail of the parotid gland
This is a retrospective study of 89 patients from China, 49 of whom were treated surgically by a partial superficial parotidectomy through retrograde approach, and 40 treated as an extracapsular dissection for benign tumours of the tail of the parotid...The central ENT decontamination model: a help or a hindrance?
According to NHS England, over 400,000 patients were waiting for ENT treatment in the UK in January 2022. This figure forms part of the overall 33.5% increase in the number of patients waiting for Referral to Treatment (RTT) compared to February 2020[1].
Can we predict how much benefit patients will get from ESS with a novel monoclonal antibody
Mepolizumab (Nucala) is a humanised IgG1 monoclonal antibody that acts as an IL-5 antagonist. It has been shown to be highly effective in treating severe asthma. It is hypothesised that it will be effective for patients with recalcitrant CRSwNP. This...Current update on vestibular and balance disorders in children
Vestibular and balance disorders in children with hearing loss often go unrecognised. This article describes the significant impact such disorders have on the various aspects of children’s development. Vestibular and balance disorders occur in the paediatric population but can go...
Management of the ear in cleft lip and palate
The management of patients with cleft lip and palate includes a focus on effective speech and language function. Poor eustachian tube function and middle ear dysfunction mean over 90% of children suffer from otitis media with effusion. This article provides...
Reducing readmission rates after transsphenoidal pituitary surgery
This retrospective study provides an outpatient care pathway to screen and manage delayed hyponatremia which the study identified as the primary cause of readmission following transsphenoidal pituitary surgery. Of the 303 patients who were studied, 27 were readmitted within 30...
